Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis
NCT02893605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2025-11-21
Summary
This is a case-control study performed on a biological collection. The polymorphisms present on a pre-defined list of genes will be studied for 400 Amyotrophic Lateral Sclerosis (sporadic type) DNA samples and 400 control DNA samples.
Conditions
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Kevin Mouzat, MD, PhD · Centre Hospitalier Universitaire de Nîmes
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- France
Study Locations
More Related Trials
-
Decoding Central Defects in Dystrophinopathies From Diagnostic to Remediation
NCT07125898 ·Status: NOT_YET_RECRUITING
-
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis
NCT06083584 ·Status: RECRUITING
-
Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis
NCT02969759 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
NCT00213824 ·Status: TERMINATED
-
Genomic Translation for Amyotrophic Lateral Sclerosis Care
NCT02795897 ·Status: COMPLETED
-
Muscular Biomarkers in Amyotrophic Lateral Sclerosis
NCT02670226 ·Status: COMPLETED ·Phase: NA
-
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
NCT05474235 ·Status: RECRUITING
-
Study of ALS Reversals 2: Genetic Analyses
NCT03464903 ·Status: COMPLETED
-
Study of ALS Reversals 4: LifeTime Exposures
NCT03706391 ·Status: COMPLETED
-
Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
NCT02152449 ·Status: COMPLETED ·Phase: NA
-
Clinical-immunological Features of DNER Ataxia
NCT05225896 ·Status: UNKNOWN
-
Study of SPG302 in Healthy Volunteers and ALS Participants
NCT05882695 ·Status: COMPLETED ·Phase: PHASE1
-
Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis
NCT01992029 ·Status: TERMINATED
-
Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis
NCT04518540 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
NCT02528071 ·Status: TERMINATED
-
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS
NCT02686268 ·Status: COMPLETED
-
Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS
NCT05852405 ·Status: COMPLETED
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis
NCT03427086 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
NCT01459302 ·Status: WITHDRAWN
-
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing
NCT04394871 ·Status: RECRUITING
-
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329 ·Status: RECRUITING
-
Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03580616 ·Status: TERMINATED ·Phase: PHASE2
-
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
NCT02532244 ·Status: COMPLETED
-
3 Year Follow up on ANO5 Patients
NCT05206617 ·Status: ACTIVE_NOT_RECRUITING